Rocket


News + Filings
Charts
Transactions


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Shin Nippon Biomedical Laboratories, Ltd. (2395) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/08/2023 4 Shin Nippon Biomedical Laboratories, Ltd. (10% Owner) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.
Txns: Bought 22,053,581 shares @ $0.91, valued at $20.1M
Bought 8,423,732 shares @ $0.91, valued at $7.7M
06/08/2023 SC 13D/A Shin Nippon Biomedical Laboratories, Ltd. reports a 100% stake in SATSUMA PHARMACEUTICALS, INC.
06/08/2023 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
05/26/2023 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
05/05/2023 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
04/17/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
04/17/2023 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
08/12/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
03/31/2021 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
02/20/2019 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
04/26/2018 SC 13D/A Shin Nippon Biomedical Laboratories, Ltd. reports a 21.1% stake in WAVE Life Sciences Ltd.
09/29/2016 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/26/2016 SC 13D/A Shin Nippon Biomedical Laboratories, Ltd. reports a 21.5% stake in WAVE Life Sciences Ltd.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy